NO20014754L - C(10)-estersubstituerte taxaner som antitumormidler - Google Patents

C(10)-estersubstituerte taxaner som antitumormidler

Info

Publication number
NO20014754L
NO20014754L NO20014754A NO20014754A NO20014754L NO 20014754 L NO20014754 L NO 20014754L NO 20014754 A NO20014754 A NO 20014754A NO 20014754 A NO20014754 A NO 20014754A NO 20014754 L NO20014754 L NO 20014754L
Authority
NO
Norway
Prior art keywords
ester
antitumor agents
substituted taxanes
taxanes
substituted
Prior art date
Application number
NO20014754A
Other languages
English (en)
Other versions
NO20014754D0 (no
NO327910B1 (no
Inventor
Robert A Holton
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of NO20014754D0 publication Critical patent/NO20014754D0/no
Publication of NO20014754L publication Critical patent/NO20014754L/no
Publication of NO327910B1 publication Critical patent/NO327910B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014754A 2000-02-02 2001-10-01 Taxaner, farmasoytiske preparater som omfatter disse, preparater for oral administrering som omfatter taxanene, samt anvendelse av taxanene til fremstilling av orale farmasoytiske preparater for inhibering av tumorvekst hos pattedyr NO327910B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17978200P 2000-02-02 2000-02-02
PCT/US2001/003623 WO2001057032A1 (en) 2000-02-02 2001-02-02 C10 ester substituted taxanes as antitumor agents

Publications (3)

Publication Number Publication Date
NO20014754D0 NO20014754D0 (no) 2001-10-01
NO20014754L true NO20014754L (no) 2001-11-29
NO327910B1 NO327910B1 (no) 2009-10-19

Family

ID=22657972

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014754A NO327910B1 (no) 2000-02-02 2001-10-01 Taxaner, farmasoytiske preparater som omfatter disse, preparater for oral administrering som omfatter taxanene, samt anvendelse av taxanene til fremstilling av orale farmasoytiske preparater for inhibering av tumorvekst hos pattedyr

Country Status (25)

Country Link
EP (1) EP1165553B1 (no)
JP (1) JP2003522172A (no)
CN (1) CN1380882A (no)
AT (1) ATE432928T1 (no)
AU (1) AU782150B2 (no)
BG (1) BG64889B1 (no)
BR (1) BR0104354A (no)
CA (1) CA2368274C (no)
CZ (1) CZ20013430A3 (no)
DE (1) DE60138853D1 (no)
GE (1) GEP20043323B (no)
HU (1) HUP0600302A2 (no)
IL (1) IL145638A (no)
MX (1) MXPA01009905A (no)
NO (1) NO327910B1 (no)
NZ (1) NZ514382A (no)
PL (1) PL202957B1 (no)
RO (1) RO121270B1 (no)
RU (1) RU2262506C2 (no)
SK (1) SK13692001A3 (no)
TR (1) TR200102858T1 (no)
TW (1) TWI299732B (no)
UA (1) UA75039C2 (no)
WO (1) WO2001057032A1 (no)
ZA (1) ZA200108055B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
SG129990A1 (en) * 2001-08-01 2007-03-20 Univ Florida State Res Found C10 ester substituted taxanes
PE20050693A1 (es) 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
US20060189679A1 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
EP2276755A4 (en) * 2008-03-31 2011-05-04 Univ Florida State Res Found C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
ES2149871T3 (es) * 1993-03-22 2000-11-16 Univ Florida State Taxanos que tienen una cadena lateral de substitucion amino.
JPH08508471A (ja) * 1993-03-22 1996-09-10 フロリダ・ステート・ユニバーシティー ピリジル置換側鎖を有するタキサン
EP1228759B1 (en) * 1993-03-22 2004-12-15 Florida State University Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
WO1996013495A1 (en) * 1994-10-28 1996-05-09 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
DE69703294T2 (de) * 1996-05-22 2001-05-17 Protarga Inc Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
CN1221539C (zh) * 1997-12-19 2005-10-05 株式会社益力多本社 紫杉烷衍生物
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
IL145638A0 (en) 2002-06-30
EP1165553B1 (en) 2009-06-03
ZA200108055B (en) 2003-12-01
MXPA01009905A (es) 2003-08-20
DE60138853D1 (de) 2009-07-16
GEP20043323B (en) 2004-02-10
PL202957B1 (pl) 2009-08-31
CA2368274C (en) 2009-10-13
TR200102858T1 (tr) 2002-12-23
CA2368274A1 (en) 2001-08-09
JP2003522172A (ja) 2003-07-22
WO2001057032A1 (en) 2001-08-09
IL145638A (en) 2011-05-31
PL351380A1 (en) 2003-04-07
AU782150B2 (en) 2005-07-07
NZ514382A (en) 2004-05-28
CN1380882A (zh) 2002-11-20
ATE432928T1 (de) 2009-06-15
AU3480901A (en) 2001-08-14
RU2262506C2 (ru) 2005-10-20
EP1165553A1 (en) 2002-01-02
BG105965A (en) 2002-07-31
CZ20013430A3 (cs) 2002-04-17
UA75039C2 (en) 2006-03-15
NO20014754D0 (no) 2001-10-01
SK13692001A3 (sk) 2002-07-02
TWI299732B (en) 2008-08-11
NO327910B1 (no) 2009-10-19
BR0104354A (pt) 2002-01-02
BG64889B1 (bg) 2006-08-31
HUP0600302A2 (en) 2006-07-28
RO121270B1 (ro) 2007-02-28

Similar Documents

Publication Publication Date Title
MY137637A (en) C7 ester substituted taxanes
NO20014756D0 (no) C(10)-heterosubstituerte acetattaksaner som antitmormidler
NO20014758L (no) C(7)-heterosubstituerte acetattaxaner som antitumormidler
NO20014754D0 (no) C(10)-estersubstituerte taksaner som antitumormidler
BG105964A (en) C(10) carbonate substituted taxanes and their use as antitumor agents
DK1165549T3 (da) C7 carbamoyloxy-substituerede taxaner som antitumormidler
NO20014760D0 (no) C(10)-karbamoyloksysubstituerte taksaner som antitumormidler
MXPA01007972A (es) Esteres de taxanos c10 sustituidos.
SG125889A1 (en) C7 ester subsituted taxanes
ATE282611T1 (de) Stolonoxide
SG125888A1 (en) C10 carbonate substituted taxanes
BR0106770A (pt) Taxanos substituìdos com éster de c7 éster

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees